Dr. Laura Marie Scheidt, MD

Dr. Scheidt practices at Cleveland Clinic Florida - Weston in Weston, Florida.

Dr. Scheidt's NPI, 1275997199, was assigned on April 6, 2016. Dr. Scheidt graduated from University of Miami, Miller School of Medicine in 2016. Dr. Scheidt holds Florida license ME140209.

Dr. Scheidt's primary practice is Cleveland Clinic Florida - Weston, at 2950 Cleveland Clinic Blvd, Weston, FL 33331 in Broward County. The practice phone is (954) 689-5000.

Dr. Scheidt's primary practice is Cleveland Clinic Florida - Weston in Weston, Florida. Dr. Scheidt is also affiliated with Cleveland Clinic Weston Hospital. The medical group on file is Paragon Contracting Services. Dmand AI also links Dr. Scheidt to 1 more hospital and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Scheidt practices, 2 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Scheidt's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Scheidt is board certified in emergency medicine by the American Board of Emergency Medicine. Dr. Scheidt is licensed in Florida.

CMS data shows 287 Medicare services from Dr. Scheidt across 4 procedure codes in 2024, for 246 Medicare patients. Medicare paid $35,430 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 246 Medicare patients who saw Dr. Scheidt in 2024. The largest group is 65 to 74, with 97 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Scheidt's median patient age at 54, with 53% women.

In 2024, Dr. Scheidt wrote 153 Medicare Part D claims for 109 patients. 90% of them were for generic drugs. CMS names the drug for 34 of them, across 2 drugs with 11 or more claims each, at $870 in total drug cost. In 2023, CMS named 46 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Scheidt for performance year 2024, reported through an alternative payment model (APM). Dr. Scheidt accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Dr. Scheidt from 1 drug or device company in 2016. Food and beverage make up the largest share, 100% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $125.

Dr. Scheidt graduated from University of Miami, Miller School of Medicine in 2016.

Dr. Scheidt is in network with 5 carriers, including United Healthcare, Molina and Blue Cross and Blue Shield of Kansas City. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.